Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03219437
Recruitment Status : Active, not recruiting
First Posted : July 17, 2017
Last Update Posted : August 19, 2019
Sponsor:
Information provided by (Responsible Party):
AbbVie

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 20, 2020
Estimated Study Completion Date : September 30, 2021